Cargando…

Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review

A 65-year-old Italian physician affected by Familial Mediterranean fever (FMF) was hospitalized due to progressive abdominal enlargement, which had begun 6 months before admission. Physical examination revealed ascites and bilateral leg edema. Abdominal CT scan showed ascitic fluid and extensive mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talerico, Rosa, Cardillo, Carmine, De Vito, Francesco, Schinzari, Francesca, Soldato, Manuel, Giustiniani, Maria Cristina, Verrecchia, Elena, Manna, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237567/ https://www.ncbi.nlm.nih.gov/pubmed/32477360 http://dx.doi.org/10.3389/fimmu.2020.00889

Ejemplares similares

Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever
por: Verrecchia, E., et al.
Publicado: (2017)

A Hypothesis Regarding Neurosecretory Inhibition of Stress Mediators by Colchicine in Preventing Stress-Induced Familial Mediterranean Fever Attacks
por: Korkmaz, Cengiz, et al.
Publicado: (2022)

Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial
por: Koga, Tomohiro, et al.
Publicado: (2018)

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
por: Calligaris, Lorenzo, et al.
Publicado: (2007)

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
por: El Hasbani, Georges, et al.
Publicado: (2019)

Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever
por: Sener, Seher, et al.
Publicado: (2023)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
por: Köhler, Birgit Maria, et al.
Publicado: (2018)

Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine
por: Berdeli, Afig, et al.
Publicado: (2019)

Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
por: Yücel, Burcu Bozkaya, et al.
Publicado: (2021)

Comparison of Different Pharmaceutical Preparations of Colchicine in Children with Familial Mediterranean Fever: Is Colchicine Opocalcium a Good Alternative?
por: Türkuçar, Serkan, et al.
Publicado: (2021)

Does switching from coated colchicine to compressed colchicine improves treatment response in patients with familial Mediterranean fever?
por: Öner, Nimet, et al.
Publicado: (2023)

An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial
por: Koga, Tomohiro, et al.
Publicado: (2020)

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
por: Gül, Ahmet, et al.
Publicado: (2015)

Intestinal malrotation as a misdiagnosis of pediatric colchicine resistant familial Mediterranean fever
por: Heshin-Bekenstein, Merav, et al.
Publicado: (2015)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma
por: Langenberg-Ververgaert, Karin P.S., et al.
Publicado: (2018)

Remission of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment
por: Odabas, Hatice
Publicado: (2006)

A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever
por: Corsia, Alice, et al.
Publicado: (2017)

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram
por: Toshida, Masamitsu, et al.
Publicado: (2021)

Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?
por: Omma, Ahmet, et al.
Publicado: (2021)

Association of Vasculitis and Familial Mediterranean Fever
por: Abbara, Salam, et al.
Publicado: (2019)

Improvement of Liver Involvement in Familial Mediterranean Fever After the Introduction of Canakinumab: A Case Report
por: Massaro, Maria Grazia, et al.
Publicado: (2020)

Coexistence of hereditary angioedema in a case of familial Mediterranean fever with partial response to colchicine
por: Bahceci, Semiha Erdem, et al.
Publicado: (2015)

Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
por: Omma, Ahmet, et al.
Publicado: (2017)

Genotype Mutations in Egyptian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine
por: Talaat, Hala S., et al.
Publicado: (2020)

COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review
por: Nas, Kemal, et al.
Publicado: (2021)

The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine resistant or intolerant FMF
por: Hashkes, P, et al.
Publicado: (2015)

Accelerated Apoptosis of Neutrophils in Familial Mediterranean Fever
por: Manukyan, Gayane, et al.
Publicado: (2015)

Colchicine Intolerance: Does the Pharmaceutical Preparation Matter?
por: İlgen, Ufuk, et al.
Publicado: (2021)

Familial Mediterranean Fever and COVID-19: Friends or Foes?
por: Stella, Alessandro, et al.
Publicado: (2020)

Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans
por: Manna, Raffaele, et al.
Publicado: (2019)

Colchicine-resistant familial Mediterranean fever in a renal transplantation patient: successful treatment with anakinra
por: Celebi, Zeynep Kendi, et al.
Publicado: (2014)

Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients
por: BODAKÇİ, Erdal, et al.
Publicado: (2021)

Effectiveness of Colchicine or Canakinumab in Japanese Patients with Familial Mediterranean Fever: A Single-Center Study
por: Yoshida, Shuhei, et al.
Publicado: (2023)

Effect of oral Colchicine on Peripapillary retinal nerve fiber layer thickness in patients with familial Mediterranean fever
por: Tanyıldız, Burak, et al.
Publicado: (2018)

Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management
por: Özen, Seza, et al.
Publicado: (2017)

Colchicine intolerance in FMF patients and primary obstacles for optimal dosing
por: SATIŞ, Hasan, et al.
Publicado: (2020)

Colchicine-induced rhabdomyolysis following a concomitant use of clarithromycin in a haemodialysis patient with familial Mediterranean fever
por: Çelebi, Zeynep Kendi, et al.
Publicado: (2013)

Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis
por: Sargin, Gokhan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ouvmhobcq9qc7jm7b4rhqcj5a1